首页 | 本学科首页   官方微博 | 高级检索  
     

配体偶联脂质体微粒和纳米粒的研究进展
引用本文:张亚红,朱照静. 配体偶联脂质体微粒和纳米粒的研究进展[J]. 药学进展, 2005, 29(11): 487-491
作者姓名:张亚红  朱照静
作者单位:重庆医科大学药学系药剂教研室,重庆,400016
摘    要:分类综述以共价键和非共价键偶联的各种配体-脂质体微粒和纳米粒的研究进展。配体-脂质体微粒和纳米粒是药物靶向转运的有效载体,可识别并特异性地结合于靶细胞,体内外实验表明其偶联方法,如配体的选择及其在微粒上的分布和结合方式等,将直接影响它们的稳定性、靶向性及配体的免疫活性。

关 键 词:脂质体  微粒  纳米粒  靶向释药  配体
文章编号:1001-5094(2005)11-0487-05
收稿时间:2005-05-08
修稿时间:2005-05-08

Development of Ligand-coupled Liposome Micro-and Nano-particles as Drug Carriers
ZHANG Ya-hong,ZHU Zhao-jing. Development of Ligand-coupled Liposome Micro-and Nano-particles as Drug Carriers[J]. Progress in Pharmaceutical Sciences, 2005, 29(11): 487-491
Authors:ZHANG Ya-hong  ZHU Zhao-jing
Affiliation:Department of Pharmacy, Chongqing University of Medical Sciences, Chongqing 400016, China
Abstract:The recent development of ligand-coupled liposome micro- and nano-particles by covalent and noncovalent bond was reviewed. These micro- and nano-particles are useful carriers for targeted drug delivery, which can recognize and bind specifically to target cells. Both in vitro and vivo studies have proved that the ligand-liposome coupling approaches, such as the choice of ligands, the distribution on the surface of particles and the binding way, would directly influence their stability and targeting property and the immunoactivity of ligands.
Keywords:Liposome  Microparticle  Nnoparticle  Targeted drug delivery  Ligand
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号